Zhong Guo Jing Ying Bao·2025-11-01 03:57Group 1 - Four delisted companies have been penalized by the China Securities Regulatory Commission (CSRC) within a month, with total fines amounting to 85.6 million yuan [1][2][3] - Qingdao Zhongcheng was fined 7.5 million yuan for false reporting and failure to disclose significant litigation matters, with additional fines of 13.1 million yuan imposed on eight responsible individuals [2][3] - Pan Hai Holdings faced penalties due to breaches in financing contracts, with unpaid debts amounting to 5.943 billion yuan in 2022 and 2.6 billion yuan in 2023, which were not disclosed in a timely manner [3][4] Group 2 - Jiangsu Sunshine and Changjiang Health are also facing penalties, with proposed fines of 3.3 million yuan and 53.3 million yuan respectively for failing to disclose related party transactions and significant guarantees [1][4] - Jiangsu Sunshine's violations include not disclosing non-operating fund occupation, while Changjiang Health is accused of failing to disclose major guarantees and related party fund occupation [4][5] - Qianshan Pharmaceutical's chairman and general manager received a two-year prison sentence for violations related to information disclosure and fund misappropriation, highlighting the criminal consequences for serious infractions [5][6] Group 3 - The regulatory environment emphasizes that delisting does not equate to immunity from penalties, as a comprehensive accountability system is being implemented [1][6] - Legal experts note that the enforcement actions target not only the companies but also key individuals, major shareholders, and intermediaries involved in fraudulent activities [6][7] - The approach aims to increase the cost of illegal activities and deter key decision-makers from engaging in misconduct [6][7]